J
Jiangsu Lanfeng Bio-chemical Co Ltd
SZSE:002513
Jiangsu Lanfeng Bio-chemical Co Ltd
SZSE:002513
Price:
6.07
CNY
-0.33%
Market Closed
Market Cap:
¥2.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
J
|
Jiangsu Lanfeng Bio-chemical Co Ltd
SZSE:002513
|
CN |
|
P
|
PVP Ventures Ltd
NSE:PVP
|
IN |
|
X
|
Xebra Brands Ltd
CNSX:XBRA
|
CA |
|
K
|
Kartonsan Karton Sanayi ve Ticaret AS
IST:KARTN.E
|
TR |
|
H
|
Hootech Inc
SZSE:301026
|
CN |
|
Aluminum Corporation of China Ltd
SSE:601600
|
CN |
|
Nexoptic Technology Corp
XTSX:NXO
|
CA |
Balance Sheet
Balance Sheet Decomposition
Jiangsu Lanfeng Bio-chemical Co Ltd
Jiangsu Lanfeng Bio-chemical Co Ltd
Balance Sheet Decomposition is not available for
Jiangsu Lanfeng Bio-chemical Co Ltd
Jiangsu Lanfeng Bio-chemical Co Ltd
Balance Sheet
Jiangsu Lanfeng Bio-chemical Co Ltd
Jiangsu Lanfeng Bio-chemical Co Ltd
Currency: CNY
| Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
25
|
72
|
99
|
871
|
367
|
256
|
150
|
172
|
428
|
312
|
123
|
92
|
150
|
227
|
33
|
9
|
16
|
65
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
33
|
9
|
16
|
65
|
|
| Cash Equivalents |
25
|
72
|
99
|
871
|
367
|
256
|
150
|
172
|
428
|
312
|
123
|
92
|
150
|
227
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
76
|
86
|
94
|
117
|
222
|
282
|
375
|
243
|
290
|
317
|
618
|
526
|
338
|
312
|
294
|
183
|
741
|
590
|
|
| Accounts Receivables |
72
|
80
|
76
|
101
|
183
|
244
|
329
|
202
|
227
|
238
|
213
|
165
|
126
|
49
|
78
|
95
|
363
|
291
|
|
| Other Receivables |
4
|
6
|
18
|
16
|
39
|
37
|
46
|
41
|
63
|
79
|
405
|
361
|
212
|
263
|
217
|
88
|
377
|
299
|
|
| Inventory |
55
|
49
|
53
|
111
|
121
|
273
|
258
|
240
|
253
|
199
|
178
|
148
|
147
|
130
|
133
|
98
|
168
|
182
|
|
| Other Current Assets |
15
|
8
|
16
|
40
|
68
|
56
|
63
|
99
|
126
|
268
|
199
|
544
|
180
|
155
|
86
|
70
|
651
|
470
|
|
| Total Current Assets |
171
|
215
|
262
|
1 139
|
779
|
867
|
846
|
753
|
1 097
|
1 097
|
1 118
|
1 310
|
815
|
823
|
546
|
360
|
1 576
|
1 308
|
|
| PP&E Net |
180
|
207
|
343
|
488
|
928
|
1 388
|
1 641
|
1 701
|
1 803
|
1 782
|
1 775
|
1 589
|
1 374
|
1 265
|
945
|
888
|
1 541
|
1 758
|
|
| PP&E Gross |
0
|
0
|
343
|
488
|
928
|
1 388
|
1 641
|
1 701
|
1 803
|
1 782
|
1 775
|
1 589
|
1 374
|
1 265
|
945
|
888
|
1 541
|
1 758
|
|
| Accumulated Depreciation |
0
|
0
|
147
|
173
|
141
|
213
|
339
|
481
|
626
|
756
|
884
|
1 110
|
1 352
|
1 403
|
1 770
|
1 490
|
1 025
|
1 137
|
|
| Intangible Assets |
28
|
38
|
47
|
19
|
36
|
68
|
77
|
75
|
107
|
110
|
105
|
87
|
80
|
50
|
47
|
44
|
59
|
62
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
803
|
803
|
803
|
230
|
22
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
47
|
49
|
62
|
66
|
63
|
61
|
50
|
4
|
4
|
12
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
5
|
5
|
5
|
5
|
4
|
4
|
3
|
3
|
5
|
5
|
4
|
15
|
83
|
84
|
85
|
|
| Other Long-Term Assets |
2
|
2
|
2
|
4
|
4
|
5
|
20
|
31
|
171
|
202
|
163
|
244
|
346
|
119
|
170
|
97
|
127
|
207
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
803
|
803
|
803
|
230
|
22
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
381
N/A
|
462
+21%
|
655
+42%
|
1 655
+153%
|
1 752
+6%
|
2 332
+33%
|
2 588
+11%
|
2 611
+1%
|
4 033
+54%
|
4 057
+1%
|
4 032
-1%
|
3 527
-13%
|
2 703
-23%
|
2 311
-14%
|
1 728
-25%
|
1 476
-15%
|
3 400
+130%
|
3 419
+1%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
68
|
49
|
70
|
66
|
117
|
260
|
267
|
231
|
283
|
261
|
237
|
217
|
391
|
412
|
500
|
553
|
1 223
|
1 334
|
|
| Accrued Liabilities |
7
|
6
|
6
|
6
|
5
|
54
|
24
|
14
|
15
|
21
|
21
|
19
|
20
|
16
|
29
|
38
|
34
|
47
|
|
| Short-Term Debt |
114
|
150
|
144
|
268
|
285
|
786
|
928
|
636
|
799
|
823
|
846
|
682
|
781
|
521
|
453
|
285
|
1 012
|
684
|
|
| Current Portion of Long-Term Debt |
5
|
10
|
25
|
36
|
90
|
102
|
35
|
99
|
111
|
131
|
98
|
221
|
137
|
145
|
0
|
1
|
1
|
35
|
|
| Other Current Liabilities |
74
|
44
|
69
|
44
|
28
|
40
|
52
|
60
|
125
|
77
|
93
|
443
|
91
|
39
|
63
|
161
|
247
|
233
|
|
| Total Current Liabilities |
268
|
257
|
314
|
419
|
525
|
1 135
|
1 259
|
1 039
|
1 333
|
1 313
|
1 295
|
1 582
|
1 420
|
1 134
|
1 045
|
1 037
|
2 517
|
2 333
|
|
| Long-Term Debt |
33
|
23
|
98
|
153
|
82
|
0
|
105
|
70
|
35
|
0
|
7
|
252
|
121
|
0
|
0
|
0
|
409
|
433
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
4
|
3
|
2
|
1
|
0
|
3
|
2
|
2
|
2
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
225
|
280
|
|
| Other Liabilities |
2
|
1
|
0
|
5
|
5
|
15
|
39
|
353
|
251
|
223
|
194
|
34
|
25
|
17
|
13
|
79
|
220
|
338
|
|
| Total Liabilities |
303
N/A
|
281
-7%
|
412
+47%
|
577
+40%
|
612
+6%
|
1 150
+88%
|
1 402
+22%
|
1 462
+4%
|
1 626
+11%
|
1 541
-5%
|
1 499
-3%
|
1 870
+25%
|
1 567
-16%
|
1 151
-27%
|
1 061
-8%
|
1 118
+5%
|
3 374
+202%
|
3 386
+0%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
55
|
55
|
55
|
74
|
133
|
213
|
213
|
213
|
340
|
340
|
340
|
340
|
340
|
340
|
340
|
374
|
374
|
375
|
|
| Retained Earnings |
20
|
123
|
185
|
265
|
327
|
359
|
361
|
324
|
255
|
365
|
382
|
495
|
1 016
|
1 005
|
1 498
|
1 817
|
2 146
|
2 400
|
|
| Additional Paid In Capital |
3
|
3
|
3
|
739
|
680
|
610
|
612
|
612
|
1 812
|
1 812
|
1 812
|
1 812
|
1 812
|
1 825
|
1 825
|
1 902
|
1 898
|
2 136
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
102
|
102
|
79
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
79
N/A
|
181
+130%
|
243
+34%
|
1 078
+343%
|
1 140
+6%
|
1 182
+4%
|
1 186
+0%
|
1 149
-3%
|
2 407
+109%
|
2 517
+5%
|
2 533
+1%
|
1 657
-35%
|
1 135
-31%
|
1 160
+2%
|
667
-43%
|
358
-46%
|
25
-93%
|
33
+29%
|
|
| Total Liabilities & Equity |
381
N/A
|
462
+21%
|
655
+42%
|
1 655
+153%
|
1 752
+6%
|
2 332
+33%
|
2 588
+11%
|
2 611
+1%
|
4 033
+54%
|
4 057
+1%
|
4 032
-1%
|
3 527
-13%
|
2 703
-23%
|
2 311
-14%
|
1 728
-25%
|
1 476
-15%
|
3 400
+130%
|
3 419
+1%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
158
|
158
|
158
|
213
|
213
|
213
|
213
|
213
|
340
|
340
|
340
|
340
|
340
|
340
|
340
|
340
|
340
|
375
|
|
Switch to:
Switch to:
See Also
Discover More
